Terence S Herman, MD
Affiliations: | 2005 | Radiation Oncology | University of Texas Health Science Center - San Antonio |
2006- | Radiation Oncology | University of Oklahoma College of Medicine |
Website:
https://stephensoncancercenter.org/Types-of-Cancer/Ovarian/Treatment-Team/terence-herman-mdGoogle:
"Terence Herman"Parents
Sign in to add mentorStephen E. Jones | grad student | University of Arizona College of Medicine | |
Sydney E. Salmon | grad student | University of Arizona College of Medicine |
Children
Sign in to add traineeClifton David Fuller | grad student | 2005 | University of Texas Health Science Center - San Antonio |
Collaborators
Sign in to add collaborator
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Richards Z, Nguyen ML, Kutteh M, et al. (2022) Ocular malignancies treated with iodine-125 low dose rate (LDR) brachytherapy at a single high-volume institution: A retrospective review. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists |
Mehta M, Griffith J, Panneerselvam J, et al. (2020) Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage. International Journal of Radiation Biology. 1-36 |
Somasundaram DB, Maher A, Aravindan S, et al. (2020) Abstract 5403: Targeting death-receptors in therapy resistant progressive neuroblastoma: A preliminary insight Cancer Research. 80: 5403-5403 |
Chiang B, Hibbitts K, Ortega H, et al. (2020) Dosimetric comparison of volumetric modulated arc therapy and intensity modulated radiation therapy for anal cancer Journal of Radiotherapy in Practice. 19: 190-192 |
Caudell JJ, Torres-Saavedra P, Rosenthal DI, et al. (2020) Long-Term Update of NRG Oncology RTOG 0522: A Randomized Phase III Trial of Concurrent Radiation and Cisplatin with or without Cetuximab in Locoregionally Advanced Head and Neck Cancer International Journal of Radiation Oncology Biology Physics. 106: 1116-1117 |
Andrade D, Mehta M, Griffith J, et al. (2019) HuR Reduces Radiation-Induced DNA Damage by Enhancing Expression of ARID1A. Cancers. 11 |
Somasundaram DB, Subramanian K, Aravindan S, et al. (2019) De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution. Scientific Reports. 9: 11766 |
Aravindan S, Somasundaram DB, Somasundaram ST, et al. (2019) Targeting acquired oncogenic burden in resilient pancreatic cancer: a novel benefit from marine polyphenols. Molecular and Cellular Biochemistry |
Schnell E, Thompson S, Ahmad S, et al. (2019) Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists |
Aravindan S, Somasundaram ST, Natarajan M, et al. (2019) Abstract 2074: Bioactive marine drugs target acquired oncogenic burden in resilient pancreatic cancer Cancer Research. 79: 2074-2074 |